International Journal of Drug Policy
Volume 21, Issue 6 , Pages 477-484 , November 2010

Availability of body art facilities and body art piercing do not predict hepatitis C acquisition among injection drug users in Montreal, Canada: Results from a cohort study

  • Julie Bruneau

      Affiliations

    • CRCHUM, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada
    • Department of Family Medicine, Université de Montréal, Montréal, Québec, Canada
    • Corresponding Author InformationCorresponding author at: CRCHUM, Centre Hospitalier de l’Université de Montréal, 264 René-Lévesque est, Room 312, Montreal, Québec, Canada H2X 1P1. Tel.: +1 514 890 8000x35882; fax: +1 514 412 7280.
    • ,
  • Mark Daniel

      Affiliations

    • CRCHUM, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada
    • Department of Social and Preventive Medicine, Université de Montréal, Montréal, Québec, Canada
    • School of Health Sciences, University of South Australia, Adelaide, Australia
    • ,
  • Yan Kestens

      Affiliations

    • CRCHUM, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada
    • Department of Social and Preventive Medicine, Université de Montréal, Montréal, Québec, Canada
    • ,
  • Michal Abrahamowicz

      Affiliations

    • Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada
    • ,
  • Geng Zang

      Affiliations

    • CRCHUM, Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada

Received 6 February 2010 ,Revised 11 May 2010 ,Accepted 12 May 2010.

References 

  1. Alter HJ, Conry-Cantilena C, Melpolder J, Tan D, Van Raden M, Herion D, et al. Hepatitis C in asymptomatic blood donors. Hepatology. 1997;26(3 Suppl. 1):29S–33S
  2. Armstrong ML. Tattooing, body piercing, and permanent cosmetics: A historical and current view of state regulations, with continuing concerns. Journal of Environmental Health. 2005;67(8):38–4354, 53
  3. Armstrong ML, Koch JR, Saunders JC, Roberts AE, Owen DC. The hole picture: Risks, decision making, purpose, regulations, and the future of body piercing. Clinical Dermatology. 2007;25(4):398–406
  4. Backmund M, Meyer K, Wachtler M, Eichenlaub D. Hepatitis C virus infection in injection drug users in Bavaria: Risk factors for seropositivity. European Journal of Epidemiology. 2003;18(6):563–568
  5. Baldo V, Baldovin T, Trivello R, Floreani A. Epidemiology of HCV infection. Current Pharmaceutical Design. 2008;14(17):1646–1654
  6. Bone A, Ncube F, Nichols T, Noah ND. Body piercing in England: A survey of piercing at sites other than earlobe. BMJ. 2008;336(7658):1426–1428
  7. Briggs ME, Baker C, Hall R, Gaziano JM, Gagnon D, Bzowej N, et al. Prevalence and risk factors for hepatitis C virus infection at an urban veterans administration medical center. Hepatology. 2001;34(6):1200–1205
  8. Brogly SB, Bruneau J, Lamothe F, Vincelette J, Franco EL. HIV-positive notification and behavior changes in Montreal injection drug users. AIDS Education and Prevention. 2002;14(1):17–28
  9. Bruneau J, Lamothe F, Soto J, Lachance N, Vincelette J, Vassal A, et al. Sex-specific determinants of HIV infection among injection drug users in Montreal. Canadian Medical Association Journal. 2001;164(6):767–773
  10. Bruneau J, Daniel M, Kestens Y, Zang G, Genereux M. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes. Journal of Epidemiology and Community Health. 2008;62(9):804–810
  11. Comité permanent de lutte à la toxicomanie. Ministère de la santé et des services sociaux . Le point sur la situation de la toxicomanie au Québec en l’an 2000. Ministère de la santé et des services sociaux. Gouvernement du Québec; 2000;<http://publications.msss.gouv.qc.ca/biblio/CPLT/publications/0900pt.pdf/> Retrieved 25.01.09
  12. Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors’ ability to practice harm reduction: A qualitative study. Social Science & Medicine. 2005;61(3):673–684
  13. Cooper HL, Bossak B, Tempalski B, Des Jarlais DC, Friedman SR. Geographic approaches to quantifying the risk environment: Drug-related law enforcement and access to syringe exchange programmes. International Journal of Drug Policy. 2009;20:217–226
  14. Daniel M, Kestens Y. Geographic information system: MEGAPHONE – Montreal epidemiological and geographic analysis of population health outcomes and neighbourhood effects. Montreal, Canada: Centre de recherche du Centre hospitalier de l’Université de Montréal; 2007;® 1046898.
  15. Daniel M, Kestens Y, Paquet C. Demographic and urban form correlates of healthful and unhealthful food availability in Montreal, Canada. Canadian Journal of Public Health. 2009;100(3):189–193
  16. De P, Cox J, Boivin JF, Platt RW, Jolly AM, Alexander PE. HIV and HCV discordant injecting partners and their association to drug equipment sharing. Scandinavian Journal of Infectious Diseases. 2009;41(3):206–214
  17. Dolan KA, Wodak AD, Hall WD. A bleach program for inmates in NSW: An HIV prevention strategy. Australian and New Zealand Journal of Public Health. 1998;22(7):838–840
  18. Falster K, Kaldor JM, Maher L. Hepatitis C virus acquisition among injecting drug users: A cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995–2004. Journal of Urban Health. 2009;86(1):106–118
  19. Flanders WD, Klein M. Properties of 2 counterfactual effect definitions of a point exposure. Epidemiology. 2007;18(4):453–460
  20. Friedman SR, Cooper HL, Tempalski B, Keem M, Friedman R, Flom PL, et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS. 2006;20(1):93–99
  21. Galea S, Ahern J, Vlahov D, Coffin PO, Fuller C, Leon AC, et al. Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug and Alcohol Dependence. 2003;70(2):139–148
  22. Genereux M, Bruneau J, Daniel M. Association between neighbourhood socioeconomic characteristics and high-risk injection behaviour amongst injection drug users living in inner and other city areas in Montreal, Canada. International Journal of Drug Policy. 2010;21(1):49–55
  23. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health. 2001;91(1):42–46
  24. Haley RW, Fischer RP. The tattooing paradox: Are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection?. Archives of Internal Medicine. 2003;163(9):1095–1098
  25. Hayes MO, Harkness GA. Body piercing as a risk factor for viral hepatitis: An integrative research review. American Journal of Infection Control. 2001;29(4):271–274
  26. Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiology and Infection. 2004;132(3):409–415
  27. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15(5):615–625
  28. Holsen DS, Harthug S, Myrmel H. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway. European Journal of Clinical Microbiology & Infectious Diseases. 1993;12(9):673–676
  29. Hutchinson SJ, Taylor A, Goldberg DJ, Gruer L. Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990–94: Implications for control and prevention of blood-borne viruses. Addiction. 2000;95(6):931–940
  30. Kazandjieva J, Tsankov N. Tattoos: Dermatological complications. Clinical Dermatology. 2007;25(4):375–382
  31. Latkin CA, Williams CT, Wang J, Curry AD. Neighborhood social disorder as a determinant of drug injection behaviors: A structural equation modeling approach. Health Psychology. 2005;24(1):96–100
  32. Laumann AE, Derick AJ. Tattoos and body piercings in the United States: A national data set. Journal of the American Academy of Dermatology. 2006;55(3):413–421
  33. Luksamijarulkul P, Deangbubpha A. Hepatitis C antibody prevalence and risk factors of some female sex workers in Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health. 1997;28(3):507–512
  34. Maas B, Fairbairn N, Kerr T, Li K, Montaner JS, Wood E. Neighborhood and HIV infection among IDU: Place of residence independently predicts HIV infection among a cohort of injection drug users. Health Place. 2007;13(2):432–439
  35. Makkai T, McAllister I. Prevalence of tattooing and body piercing in the Australian community. Communicable Diseases Intelligence. 2001;25(2):67–72
  36. McGovern BH, Wurcel A, Kim AY, Schulze zur Wiesch J, Bica I, Zaman MT, et al. Acute hepatitis C virus infection in incarcerated injection drug users. Clinical Infectious Diseases. 2006;42(12):1663–1670
  37. O’Brien SF, Fan W, Xi G, Yi QL, Goldman M, Fearon MA, et al. Declining hepatitis C rates in first-time blood donors: Insight from surveillance and case-control risk factor studies. Transfusion. 2008;48(5):902–909
  38. Perez CM, Suarez E, Torres EA, Roman K, Colon V. Seroprevalence of hepatitis C virus and associated risk behaviours: A population-based study in San Juan, Puerto Rico. International Journal of Epidemiology. 2005;34(3):593–599
  39. Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Social Science & Medicine. 2005;61(5):1026–1044
  40. Rotily M, Delorme C, Obadia Y, Escaffre N, Galinier-Pujol A. Survey of French prison found that injecting drug use and tattooing occurred. BMJ. 1998;316(7133):777
  41. Roy E, Haley N, Leclerc P, Boivin JF, Cedras L, Vincelette J. Risk factors for hepatitis C virus infection among street youths. Canadian Medical Association Journal. 2001;165(5):557–560
  42. Sampson R, Raudenbush S. Systematic social observation of public spaces: A new look at disorder in urban neighborhoods. American Journal of Sociology. 1999;105(3):603–651
  43. Savoie, J., Bédard, F., & Collins, K., 2006. Neighbourhood characteristics and the distribution of crime on the Island of Montréal. Crime and justice research paper series. Statistics Canada Catalogue no. 85-561-MIE. No. 7. Ottawa.
  44. Scheinmann R, Hagan H, Lelutiu-Weinberger C, Stern R, Des Jarlais DC, Flom PL, et al. Non-injection drug use and hepatitis C virus: A systematic review. Drug and Alcohol Dependence. 2007;89(1):1–12
  45. Tyndall MW, Currie S, Spittal P, Li K, Wood E, O'Shaughnessy MV, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003;17(6):887–893
  46. van Haastrecht HJ, Bax JS, van den Hoek AA. High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons. Addiction. 1998;93(9):1417–1425
  47. Wallace R, Wallace D. Community marginalisation and the diffusion of disease and disorder in the United States. British Medical Journal. 1997;314:1341–1345
  48. Zou S, Forrester L, Giulivi A. Hepatitis C update. Canadian Journal of Public Health. 2003;94(2):127–129

PII: S0955-3959(10)00075-7

doi: 10.1016/j.drugpo.2010.05.001

International Journal of Drug Policy
Volume 21, Issue 6 , Pages 477-484 , November 2010

Article Tools

* Image Usage & Resolution